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The C-terminal flanking peptide of preprocholecystokinin has been isolated from rat brain. Micro-sequence 
analysis revealed the primary structure: Ser-Ala-Glu-Asp-Tyr-Glu-Tyr-Pro-Ser. Arylsulphatase and mild 
acid hydrolysis suggested that both tyrosine residues are sulphated. The peptide was not active in bioassay 
systems that respond to CCKS; the significance of the conserved tripeptide Ser-Ala-Glu is discussed. 
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1. INTRODUCTION 
Cholecystokinin (CCK) acts in the gut as a hor- 
mone controlling the gall bladder and pancreas, 
and in the brain it is a possible peptide transmitter 
produced by various neurones including mesolim- 
bit dopaminergic neurones and some cortical 
GABA neurones [1,2]. Recently the cDNA se- 
quences complementary to the mRNA encoding 
rat, mouse, human and porcine preprocholecys- 
tokinin @reproCCK) have been elucidated [3-71. 
Although these data reveal the primary amino acid 
sequence of the precursor they provide little insight 
into post-translational processing pathways. It has 
been clear for some time that there are differences 
in post-translational processing of the CCK 
precursor in brain and gut [ 1,2], but the 
mechanisms involved are uncertain. In both cases, 
processing of the precursor at the sequence -Phe- 
Gly-Arg-Arg-Ser- is expected to generate the Phe- 
amide which is the common C-terminal residue of 
the known biologically active forms (fig.1). 
Cleavage here should also liberate a C-terminal 
flanking peptide, which is of interest because it 
* To whom correspondence should be addressed 
should contain a tripeptide sequence (Ser-Ala-Glu) 
identical to that in the corresponding region of the 
precursor for the related hormone gastrin [8-lo]. 
We have recently developed a radioimmunoassay 
(RIA) for the C-terminal flanking peptide of rat, 
human and mouse preproCCK [l l] and we have 
now used it to monitor the isolation of this peptide 
from rat brain. 
2. MATERIALS AND METHODS 
2.1. Isolation 
Rats were decapitated and the brains quickly 
removed and frozen on dry ice. They were later ex- 
tracted in boiling water, centrifuged (50000 x g, 
30 min) and the supernatants lyophilized and 
stored at -20°C. The extracts were subsequently 
dissolved in water (20 g-l-‘), and fractionated by 
gel filtration on Sephadex G50 fine (5 x 100 cm) in 
0.05 M ammonium bicarbonate. Tubes containing 
the immunoreactivity were then applied to an 
amino ethyl (AE) cellulose ion-exchange column (1 
x 15 cm) equilibrated with 0.05 M triethylamine 
(pH 7.0 after gassing with COZ) and eluted with a 
gradient to 0.5 M triethylamine (pH 11.5). Tubes 
containing immunoreactivity were lyophilized and 
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further purified on HPLC, using three reversed- 
phase systems in turn. (1) A FBondapak Cl8 car- 
tridge in Waters Z-module equilibrated with 0.1% 
heptafluorobutyric acid (HFBA) and eluted with a 
gradient of acetonitrile using an Altex HPLC 
system. (2) A pBondapak Cl8 cartridge in a 
Waters Z-module equilibrated with 0.1% 
trifluoroacetic acid (TFA) and eluted with an 
acetonitrile gradient. (3) Techsil Crs 5 /rm column 
(5 x 250 mm) eluted with an acetonitrile gradient 
in 0.1% TFA. At each step the purification was 
monitored by RIA using an antibody raised to the 
extreme C-terminal pentapeptide of preproCCK 
Ill]. The label was iodinated synthetic YEYPS 
Predicted sequance Trp - Met -Asp - Phe - Gly - Arg - Arg - !ier - Ala-Glu-Asp-Tyr-Glu-Tyr-Pro-Ser. 
Observed sequence ER- ALA-GLU-ASP- TYR-UU-TYR-PRO-SER. 
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Fig. 1. Amino acid sequence of the C-terminal region of rat preproCCK predicted from the cDNA sequence (top) and 
the observed sequence of the nonapeptide isolated in this study. The antibody used in RIA was raised to the C-terminal 
pentapeptide and reacts with both the synthetic and natural peptides. 
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Fig.2. Purification by gel filtration and ion-exchange chromatography of rat brain boiling water extracts. (B) Sephadex 
G50 (5 x 100) eluted with 0.65 M ammonium bicarbonate. Tubes with immunoreactivity (1250-1420 ml) were applied 
to AE cellulose ion-exchange chromatography columns (A) eluted with a gradient of triethylamine. 
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(obtained from CRB, Harston, Cambridge, 
England), and this peptide was also used as 
standard. 
2.2. Amino acid sequence 
Approx. 2 nmol of homogeneous peptide was 
obtained from the final HPLC step. A sample of 
500 pmol was taken for microsequence analysis us- 
ing an Applied Biosystems gas-phase sequenator, 
and HPLC detection of phenylthiohydantoin 
(PTH) derivatives. The possible sulphation of 
tyrosine residues was examined by mild acid 
hydrolysis in 0.1 M HCl (100°C; 5 min) or diges- 
tion with 200-400 cg arylsulphatase (Sigma, VIII) 
dissolved in 0.2 M sodium acetate buffer (pH 5.0, 
2 h, 37°C). 
2.3. Bioassays 
The actions of the purified peptide were studied 
on guinea pig gall bladder in vitro, guinea pig il- 
eum in vitro, rat pancreatic acinar cells in vitro 
(kindly performed by Dr J. Calam), and rat 
stomach relaxation in vivo. Concentration or doses 
of the purified peptide were determined by RIA 
and were similar to those of CCK8 (l-20 nM) giv- 
ing responses in the same systems. 
3. RESULTS AND DISCUSSION 
A single major peak of activity was found in 
eluates of the gel filtration and ion-exchange col- 
umns using the present RIA (fig.2). This material 
was recovered in good yields (>80%) as a single 
peak after each of three HPLC steps. The final 
stage gave approx. 2 rim01 of material from 50 g 
rat brain in a form suitable for structural studies 
(fig.3). Microsequence analysis of 500 pmol 
revealed a primary amino acid sequence identical 
to that of the C-terminal nonapeptide of 
preproCCK predicted from the cDNA sequence 
(fig.1). HPLC detection of the PTH derivatives 
identified tyrosine in the unsulphated form at the 
appropriate cycles. The sequence analysis involved 
exposure of the peptide to gaseous TFA at 45°C; 
it seems likely that these conditions might 
desulphate previously sulphated tyrosines. Consis- 
tent with this, incubation of the pure native pep- 
tide with arylsulphatase converted into the im- 
munoreactive material to a more hydrophobic pep- 
tide on HPLC through at least one intermediate, 
suggesting that both tyrosines occurred in the 
sulphated form. Similar results were obtained with 
hydrolysis by 0.1 M HCI which is known to 
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Fig.3. Final separation of the C-terminal flanking peptide of preproCCK by HPLC on Techsil Cls 5 pm (5 x 200 mm) 
equilibrated with 0.1070 TFA and eluted with a gradient of acetonitrile (broken line). 
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desulphate CCK8 and caerulein (fig.4) [12]. Even 
the very mild acid conditions (pH 5, 37’C, 2 h) 
needed for optimal arylsulphatase activity produce 
partial desulphation, suggesting that at least one of 
the sulphated tyrosines is particularly labile. While 
the present work was in progress, two other 
laboratories described assays using antibodies 
specific for the unsulphated C-terminal proCCK 
fragment [ 13,141. In these studies, desulphation of 
the native peptide was necessary to generate im- 
munoreactive material. In contrast, the antibody 
used to monitor purification in this study appears 
; L 1. ,O.lNNCl,l00*C,Sm~n 
~ETLNTION TIME (mln) 
Fig.4. HPLC profiles of acid hydrolysis and 
arylsulphatase-treated proCCK flanking peptide. 
Samples were run on a Techsil Cis 5 /cm column 
equilibrated with 0.1% TFA and eluted with a gradient 
of acetonitrile. Panels: A, intact peptide; B, mild acid 
hydrolysis, control incubation for arylsulphation 
(sodium acetate pH 5.0 for 2 h at 37’C); C and D, 
arylsulphatase 200,ug and 4OOpg, respectively (2 h at 
37°C in sodium acetate buffer pH 5.0); E, acid 
hydrolysis (boiling in 0.1 M HCl for 5 mm). 
to react equally with the sulphated and 
desulphated peptides. 
The purified rat brain peptide was without ac- 
tivity on four tissues all of which respond to 
CCK8: guinea pig gall bladder and ileum, and rat 
pancreas acinar cell and stomach. These ex- 
periments were carried out using quantities of 
flanking peptide similar to those of CCKI, both 
alone and together with CCK8. The present assay 
systems would have detected peptides not only 
with CCK-like activity, but also with opioid-, 
VIP-, bombesin- and tachykinin-like properties 
[ 151. The evident lack of activity of the C-terminal 
fragment of proCCK is of interest in view of the 
fact that the initial tripeptide sequence, Ser-Ala- 
Glu-, is identical to that in the corresponding 
region of the precursor for the related hormone, 
gastrin. Conservation is presumably related to 
biological importance; one possibility is that this 
region is important for the appropriate post- 
translational processing at the adjacent Gly-Arg- 
Arg sequence. The Ser-Ala-Glu tripeptide may 
facilitate the action of the enzyme that carries out 
the initial cleavage between Arg-Ser. 
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